Busan, South Korea

Eun Hye Yoon

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Parenchyma Biotech Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eun Hye Yoon. Retrieved from https://idiyas.com/inventor/eun-hye-yoon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Inventor Eun Hye Yoon in Autoimmune Disease Treatment

Introduction: Eun Hye Yoon, an accomplished inventor based in Busan, South Korea, is making significant strides in the field of pharmaceutical innovations. With a focus on developing compounds for treating autoimmune diseases and various cancers, Yoon's work reflects a commitment to advancing medical treatments that impact lives on a global scale.

Latest Patents: Eun Hye Yoon holds two patents, both centered around a groundbreaking compound aimed at treating autoimmune diseases. The patented compound, represented by a specific formula, is designed for the treatment and prevention of a range of autoimmune diseases including inflammatory bowel disease, multiple sclerosis, graft-versus-host disease, asthma, atopy, psoriasis, rheumatoid arthritis, systemic lupus erythematous, and type 1 diabetes. Additionally, the compound shows potential applications in combating various cancers such as colon cancer, melanoma, liver cancer, gliocytoma, ovarian cancer, colorectal cancer, head and neck cancer, bladder cancer, kidney cell cancer, stomach cancer, breast cancer, metastatic cancer, prostate cancer, gallbladder cancer, pancreatic cancer, blood cancer, skin cancer, and lung cancer.

Career Highlights: Yoon is currently affiliated with Parenchyma Biotech Inc., a company known for its innovative approaches in biotechnology and pharmaceuticals. Through her role, she has contributed significantly to the development of novel treatments that address critical health issues, reflecting her passion and expertise.

Collaborations: In her professional journey, Eun Hye Yoon collaborates with talented individuals such as Su Kil Seo and Soung Min Lee. These collaborations foster a creative and dynamic environment that encourages the exchange of ideas and enhances the innovation process within the company.

Conclusion: As an inventor, Eun Hye Yoon epitomizes the spirit of innovation and dedication to improving healthcare outcomes. With her ongoing contributions and successful patents, she continues to pave the way for future advancements in the treatment of autoimmune diseases and cancers, inspiring future generations of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…